Clopidogrel and thrombocytopenia. A case report;Clopidogrel et thrombopénie. À propos d'un cas

Annales de Cardiologie et d'Angeiologie

Volumn 52, Issue 3, 2003, Pages 191-193

  Helft, G ^a,b,e   Elalamy, I ^c   Laudy, C ^a   Tran, D ^d   Beygui, F ^b   Le Feuvre, C ^b   Ounissi, F ^a   Monnet de Lorbeau, B ^a   Khellaf, C ^a   Metzger, J P ^b  

^a Serv de Readaptation Cardiovasc   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔTEL DIEU   (France)

^d Laboratoire de Biologie   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Clopidogrel; Thienopyridine; Thrombocytopenia

Indexed keywords

CLOPIDOGREL;

ADULT; ARTICLE; BLEEDING; CASE REPORT; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG SAFETY; EXPERIENCE; HUMAN; MALE; THROMBOCYTOPENIA; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; STENTS; THROMBOCYTOPENIA; TICLOPIDINE;

EID: 0038051353     PISSN: 00033928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-3928(02)00185-3     Document Type: Article

References (15)

1. Cannan CR. Antithrombotic therapy in cardiac stent patients. Curr Cardiol Rep 2001;3:78-84.
2. Yusuf S, Zhao F, Mehta SR, Chrolavicius, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345: 494-502.
3. Herbert JM, Frechel D, Vallee E, et al. Clopidogrel, a novel antiplatelet and antithrombotic agent. Cardiovasc Drug Rev 1993;11:180-98.
4. Helft G, Osende JI, Worthley SG, et al. Acute antithrombotic effect of a front-loaded regimen of clopidogrel in patients with atherosclerosis on aspirin. Arterioscler Thromb Vasc Biol 2000;20:2316-21.
5. Bennett CL, Connors JM, Carwile JL, et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000;342: 1773-7.
6. Harker LA, Boissel JP, Pilgrim AJ, Gent M. Comparative safety and tolerability of clopidogrel and aspirin. Drugs Safety 1999;4:325-35.
7. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001;135:502-6.
8. Elalamy I, Page Y, Viallon A, Tardy B, Conard J, Helft G. Diagnostic et gestion des thrombopénies induites par l'héparine. Rev Mal Resp 1999;16:961-74.
9. Barragan P, Sainsous J, Silvestri M, et al. Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: prospective study of 1,051 consecutive patients. Cathet Cardiovasc Diagn 1997;42:367-73.
10. Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (Fantastic) study. Circulation 1998;98:1597-603.
11. Steinbuhl SR, Tan WA, Foody JM, et al. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. JAMA 1999;281:806-10.
12. Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH, Investigators FT. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000;102:624-9.
13. CAPRIE steering committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk for ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
14. Elmi F, Peacock T, Schiavone J. Isolated profound thrombocytopenia associated with clopidogrel. J Invas Cardiol 2000;12:532-5.
15. Reichenberger F, Wirtz H, Paschke. Clopidogrel and side effects. Cardiology 2001;98:51-2.